Jason Lettmann - Sep 8, 2023 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Chief Executive Officer, Director
Signature
/s/ Peter Garcia, by power of attorney
Stock symbol
ALXO
Transactions as of
Sep 8, 2023
Transactions value $
$0
Form type
4
Date filed
9/12/2023, 04:24 PM
Previous filing
Jun 22, 2023
Next filing
Feb 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Employee Stock Option (right to buy) Award $0 +1.2M $0.00 1.2M Sep 8, 2023 Common Stock 1.2M $4.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option vest on September 5, 2024 and 1/48th of the shares vest monthly thereafter.